Ann: Trading Halt, page-5

Looks like the 2019 financial report was a bit confusing??

"Guidance confirmed: Cellmid is on track to reach operating profitability in
the consumer health business in FY2020"

I guess they were just being specific in that the "Consumer health" business unit may be operating profitably in 2020 but the rest of the business will continue to burn any spare profit and more. Seems funny how anyone can keep raising cash and keep paying anyone 400k plus in the company and not worry about cash sustainability. Surely the sensible thing would be to get the company in the black then pay yourself?? I guess we should just be grateful Evolis is selling otherwise the company would be dead.